We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+5.59%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$169M
AUM Growth
-$13M
(-7.2%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-10.58%
Top 10 Holdings %
Top 10 Hldgs %
6.26%
Holding
495
New
55
Increased
122
Reduced
257
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$947K |
| 2 |
Moderna
MRNA
|
+$899K |
| 3 |
Meta Platforms (Facebook)
META
|
+$895K |
| 4 |
Netflix
NFLX
|
+$876K |
| 5 |
Chipotle Mexican Grill
CMG
|
+$852K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.01M |
| 2 |
Progressive
PGR
|
+$999K |
| 3 |
Stryker
SYK
|
+$984K |
| 4 |
Republic Services
RSG
|
+$973K |
| 5 |
Linde
LIN
|
+$966K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.98% |
| 2 | Technology | 15.96% |
| 3 | Financials | 11.34% |
| 4 | Energy | 8.43% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXLC
126
Oxford Lane Capital
OXLC
$830M
| $533K | 0.32% |
22,022
-1,933
| -8% | -$49.4K |
|
127
Goldman Sachs BDC
GSBD
$975M
| $478K | 0.28% |
34,519
+6,368
| +23% | +$86.5K |
|
128
TriplePoint Venture Growth BDC
TPVG
$180M
| $478K | 0.28% |
40,585
+462
| +1% | +$5.22K |
|
|
XFLT
129
XAI Floating Rate & Alternative Income Trust
XFLT
$268M
| $452K | 0.27% |
13,543
-1,866
| -12% | -$60.9K |
|
130
Nuveen Credit Strategies Income Fund
JQC
$702M
| $445K | 0.26% |
88,213
-12,470
| -12% | -$62.2K |
|
131
Crescent Capital BDC
CCAP
$399M
| $432K | 0.26% |
28,545
-4,979
| -15% | -$69.8K |
|
132
WhiteHorse Finance
WHF
$141M
| $427K | 0.25% |
33,285
-2,469
| -7% | -$30.1K |
|
133
FS KKR Capital
FSK
$2.98B
| $421K | 0.25% |
21,946
-2,648
| -11% | -$50.1K |
|
134
MidCap Financial Investment
MFIC
$784M
| $406K | 0.24% |
32,337
-7,633
| -19% | -$89K |
|
135
Braskem
BAK
$980M
| $402K | 0.24% |
34,471
+2,224
| +7% | +$21.1K |
|
136
Bain Capital Specialty
BCSF
$802M
| $395K | 0.23% |
29,208
-5,248
| -15% | -$64.9K |
|
137
BlackRock TCP Capital
TCPC
$265M
| $392K | 0.23% |
35,933
+8,617
| +32% | +$90.4K |
|
138
SLR Investment Corp
SLRC
$706M
| $390K | 0.23% |
27,314
-5,189
| -16% | -$74.3K |
|
|
ECC
139
Eagle Point Credit Company
ECC
$472M
| $389K | 0.23% |
38,267
-22,942
| -37% | -$249K |
|
140
Agios Pharmaceuticals
AGIO
$2.16B
| $378K | 0.22% |
13,355
+3,423
| +34% | +$85.2K |
|
141
Halozyme
HALO
$9.72B
| $376K | 0.22% |
10,422
+5,160
| +98% | +$176K |
|
142
Insmed
INSM
$23.2B
| $376K | 0.22% |
17,814
+2,408
| +16% | +$45.7K |
|
|
BPMC
143
DELISTED
Blueprint Medicines
BPMC
| $370K | 0.22% |
5,848
-745
| -11% | -$40.5K |
|
|
IMGN
144
DELISTED
Immunogen Inc
IMGN
| $366K | 0.22% |
19,392
-40,181
| -67% | -$474K |
|
|
FCT
145
First Trust Senior Floating Rate Income Fund II
FCT
$251M
| $366K | 0.22% |
36,940
-6,149
| -14% | -$59.5K |
|
146
Vanda Pharmaceuticals
VNDA
$312M
| $361K | 0.21% |
54,805
+12,265
| +29% | +$78.6K |
|
147
Capital Southwest
CSWC
$1.46B
| $361K | 0.21% |
18,296
-7,132
| -28% | -$131K |
|
148
Roivant Sciences
ROIV
$25.2B
| $357K | 0.21% |
35,389
-7,271
| -17% | -$65K |
|
149
Immunocore
IMCR
$1.78B
| $357K | 0.21% |
5,949
+722
| +14% | +$41.2K |
|
150
Prospect Capital
PSEC
$1.06B
| $355K | 0.21% |
57,223
+5,139
| +10% | +$33K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
ALS
Virtus ETF Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, Virtus ETF Advisers held 495 positions worth $169M, down 7.2% from $182M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Virtus ETF Advisers withdrew a net $17.8M in Q2 2023, closing 60 positions and reducing 257 holdings. Its most notable exit was Activision Blizzard, an estimated $1.01M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
Against the trend, Virtus ETF Advisers opened a new position in NVIDIA worth $1.21M.
- Virtus ETF Advisers's largest Q2 2023 buy was NVIDIA: 28,520 shares worth $1.21M.
- Virtus ETF Advisers added most to Moderna in Q2 2023, an estimated $899K increase.
- Virtus ETF Advisers's biggest Q2 2023 reduction was Dow Inc, cutting an estimated $898K.
- Virtus ETF Advisers fully exited Activision Blizzard in Q2 2023, selling an estimated $1.01M.
- Virtus ETF Advisers's ten largest holdings make up 6.3% of its $169M portfolio in Q2 2023.
- Virtus ETF Advisers opened 55 new positions and closed 60 in Q2 2023.
- Virtus ETF Advisers's portfolio value fell 7.2% quarter-over-quarter to $169M.
Based on Virtus ETF Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.